195 related articles for article (PubMed ID: 8695855)
1. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
[TBL] [Abstract][Full Text] [Related]
3. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
[TBL] [Abstract][Full Text] [Related]
6. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
7. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
Lund FE; Yu N; Kim KM; Reth M; Howard MC
J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726
[TBL] [Abstract][Full Text] [Related]
8. CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.
Silvennoinen O; Nishigaki H; Kitanaka A; Kumagai M; Ito C; Malavasi F; Lin Q; Conley ME; Campana D
J Immunol; 1996 Jan; 156(1):100-7. PubMed ID: 8598449
[TBL] [Abstract][Full Text] [Related]
9. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx.
Michel F; Merle-Béral H; Legac E; Michel A; Debré P; Bismuth G
J Immunol; 1993 Apr; 150(8 Pt 1):3624-33. PubMed ID: 8096854
[TBL] [Abstract][Full Text] [Related]
10. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.
Kikuchi Y; Yasue T; Miyake K; Kimoto M; Takatsu K
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11814-8. PubMed ID: 8524855
[TBL] [Abstract][Full Text] [Related]
11. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
12. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
[TBL] [Abstract][Full Text] [Related]
13. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
14. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene.
Kitanaka A; Ito C; Nishigaki H; Campana D
Blood; 1996 Jul; 88(2):590-8. PubMed ID: 8695807
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
16. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
19. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
